Keywords: urinary bladder; carcinoma; mortality; health services accessibility; neoadjuvant therapy; MIBC; muscle invasive bladder cancer; NAC; neoadjuvant chemotherapy; NCDB; National Cancer Database; RC; radical cystectomy;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: TINs; tumor-infiltrating neutrophils; TILs; tumor-infiltrating lymphocytes; NLR; neutrophil/lymphocyte rate; BC; bladder cancer; IHC; immunohistochemistry; OS; overall survival; NMIBC; non-muscle invasive bladder cancer; MIBC; muscle invasive bladder canc
Keywords: urinary bladder neoplasms; neoplasm invasiveness; neoplasm recurrence; local; BCG vaccine; mortality; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CR; complete response; DSS; disease specific survival; MIBC; muscle invasive bladder cancer; NMIB
Keywords: Elderly; MIBC; Outcome; Complications;
Keywords: urinary bladder neoplasms; carcinoma; programmed cell death 1 receptor; immunotherapy; APC; antigen-presenting cell; BCG; bacillus Calmette-Guérin; CD; cluster of differentiation; CR; complete response; CTLA-4; cytotoxic T-lymphocyte-associated antigen-4
Keywords: urinary bladder neoplasms; neoplasm invasiveness; drug therapy; cystectomy; delivery of health care; DS; definitive surgery; MIBC; muscle invasive bladder cancer; NAC; neoadjuvant chemotherapy; NCDB; National Cancer Database; Q; quartile; SC; systemic che
Keywords: CIS; carcinoma in situ; MIBC; muscle-invasive bladder cancer; NMIBC; non-muscle-invasive bladder cancer; RC; radical cystectomy; TURBT; transurethral resection of bladder tumour; Bladder cancer; TURBT; T1G3;
Keywords: CPEX; cardio-pulmonary exercise testing; LOS; length of stay; MIBC; muscle-invasive bladder cancer; NMIBC; non-muscle invasive disease; RC; radical cystectomy; Bladder cancer; Elderly; Cystectomy; Minimally invasive; Laparoscopy;
Keywords: e-waste; electronic waste; PCBs; printed circuit boards; CAH; Contact Angle Hysteresis; MIBC; Methyl Isobutyl Carbinol; θA; advancing contact angle; θR; resending contact angle; Wettability; Contact angle; Inverse flotation; Recycling; Printed circuit b
Keywords: AJCC; American Joint Committee on Cancer; AUA; American Urological Association; CTU; Computed tomography urography; DWI; diffusion-weighted imaging; MIBC; muscle invasive bladder cancer; NCCN; National Comprehensive Cancer Network; NMIBC; non-muscle invas
Keywords: MIBC; Neoadjuvant therapy; NLR; RC; Urothelial cancer;
Keywords: urinary bladder neoplasms; cystectomy; neoplasm recurrence; local; patient selection; morbidity; BCa; bladder cancer; BCG; bacillus Calmette-Guérin; CG; Clavien grade; CIS; carcinoma in situ; DSS; disease specific survival; LVI; lymphovascular invasion;
Keywords: urinary bladder neoplasms; cystectomy; health care reform; urology; health services accessibility; MIBC; muscle invasive bladder cancer; NCDB; National Cancer Database; PLND; pelvic lymph node dissection; RC; radical cystectomy; SEER; Surveillance, Epidem
Keywords: urinary bladder; carcinoma; papillary; evidence-based practice; practice guideline; risk; AUA; American Urological Association; CIS; carcinoma in situ; CTU; computerized tomography urogram; EAU; European Association of Urology; ICUD; International Consult
Keywords: urinary bladder; carcinoma; urothelium; gene expression; biological markers; CIS; carcinoma in situ; Cq; cycle quantification; HG; high grade; LG; low grade; LOOCV; leave-one-out cross validation; MIBC; muscle invasive bladder cancer; NMIBC; nonMIBC; PCR;
The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients
Keywords: BC; bladder cancer; NMIBC; non muscle invasive bladder cancer; MIBC; muscle invasive bladder cancer; EAU; European association of urology; EORTC; European Organisation for Research and Treatment of Cancer.; TUR; trans-urethral resection; BCG; Bacillus of
Determination of the concentration of MIBC in coking coal flotation
Keywords: Frother concentration; MIBC; Flotation; Absorbance; Pyrene; Cyclodextrin;
Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer Database
Keywords: urinary bladder neoplasms; aged; chemoradiotherapy; cystectomy; mortality; CCI; Charlson-Deyo comorbidity index; CRT; chemoradiation therapy; MIBC; muscle invasive bladder cancer; NCDB; National Cancer Database; OS; overall survival; RC; radical cystectom
Increased expression of GGN promotes tumorigenesis in bladder cancer and is correlated with poor prognosis
Keywords: GGN; gametogenetin; QRT-PCR; quantitative real-time PCR; BrdU; bromodeoxyuridine; MIBC; muscle-invasive bladder cancer; NMIBC; non-muscle-invasive bladder cancer; CRISP2; cysteine-rich secretory protein 2; FANCL; Fanconi anemia complementation group L; FA
Predicting the tumorigenic phenotype of human bladder cancer cells by combining with fetal rat mesenchyme
Keywords: Invasive bladder cancer; Responsiveness of cancer cells to stroma; Fetal mesenchyme; Micropapillary-like structures; p63 isoforms; BLM; bladder mesenchyme; CIS; carcinoma in situ; EMT; epithelial-mesenchymal transition; H&E; hematoxylin and eosin; MIBC; m
The Promise and Disappointment of Neoadjuvant Chemotherapy and Transurethral Resection for Muscle Invasive Bladder Cancer: Updated Results and Long-Term Followup
Keywords: urinary bladder neoplasms; neoadjuvant therapy; drug therapy; survival; CSS; cancer specific survival; MFS; metastasis-free survival; MIBC; muscle invasive urothelial carcinoma of the bladder; NAC; neoadjuvant chemotherapy; OS; overall survival; RC; radic
Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project
Keywords: urinary bladder neoplasms; neoplasm invasiveness; watchful waiting; risk; cost-benefit analysis; AS; active surveillance; IOF; in-office fulguration; LG; low grade; MIBC; muscle invasive bladder cancer; NMIBC; nonMIBC; TUR; transurethral resection; TURBT;
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline
Keywords: urinary bladder neoplasms; radiotherapy; cystectomy; drug therapy; AC; adjuvant chemotherapy; AHRQ; Agency for Healthcare Research and Quality; ASCO; American Society of Clinical Oncology; ASTRO; American Society for Radiation Oncology; AUA; American Uro
Research articleDiagnostic performance of MRI for prediction of muscle-invasiveness of bladder cancer: A systematic review and meta-analysis
Keywords: MIBC; muscle-invasive bladder cancer; TUR; transurethral resection; MRI; magnetic resonance imaging; T1WI; T1-weighted imaging; T2WI; T2-weighted imaging; CE; contrast-enhanced; DWI; diffusion-weighted imaging; PRISMA; Preferred Reporting Items for System
Management of Muscle-Invasive Urothelial Cancer and the Emerging Role of Immunotherapy in Advanced Urothelial Cancer
Keywords: AKT; AKT serine/threonine kinase 1; BCG; bacillus Calmette-Guérin; CTLA4; cytotoxic T-lymphocyte-associated protein 4; EGFR; epidermal growth factor receptor; FDA; Food and Drug Administration; FGFR; fibroblast growth factor receptor; GC; gemcitabine p
Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5α-Reductase Inhibitor
Keywords: bladder neoplasms; neoplasm recurrence; local; androgen antagonists; prevention and control; 5-alpha reductase inhibitors; ADT; androgen deprivation therapy; AR; androgen receptor; AST; androgen suppression therapy; BCG; bacillus Calmette-Guérin; BPH; be
FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study
Keywords: urinary bladder neoplasms; neoplasm recurrence; local; urinalysis; cystoscopy; neoplasm invasiveness; CIS; carcinoma in situ; EAU; European Association of Urology; HG; high grade; LG; low grade; MIBC; muscle invasive bladder cancer; NMIBC; nonmuscle inva
Association between the Absolute Baseline Lymphocyte Count and Response to Neoadjuvant Platinum-based Chemotherapy in Muscle-invasive Bladder Cancer
Keywords: Bladder cancer; chemosensitivity; lymphocytes; MIBC; neoadjuvant chemotherapy; urothelial carcinoma;
Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy
Keywords: urinary bladder neoplasms; cystectomy; thromboembolism; neoadjuvant therapy; drug therapy; CT; computerized tomography; DVT; deep vein thrombosis; MIBC; muscle invasive bladder cancer; MVAC; methotrexate, vinblastine, doxorubicin and cisplatin; NAC; neoa
A Review of Neoadjuvant and Adjuvant Chemotherapy for Nonmetastatic Muscle Invasive Bladder Cancer
Keywords: urinary bladder neoplasms; cystectomy; chemotherapy, adjuvant; neoadjuvant therapy; mortality; AC; adjuvant chemotherapy; CMV; cisplatin, methotrexate and vinblastine; ddMVAC; dense dose MVAC; eGFR; estimated glomerular filtration rate; EORTC; European Or
Sequential bacillus Calmette-Guérin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes
Keywords: urinary bladder neoplasms; Mycobacterium bovis; mitomycin; drug delivery systems; treatment outcome; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; EMDA; electromotive drug administration; HR; high risk; MIBC; muscle invasive bladder cancer; MMC;
Transurethral Bladder Tumor Resection Can Cause Seeding of Cancer Cells into the Bloodstream
Keywords: urinary bladder neoplasms; neoplastic cells; circulating; neoplasm metastasis; CTC; circulating tumor cell; CV; central vein; IVC; inferior vena cava; MIBC; muscle invasive bladder cancer; NMIBC; nonmuscle invasive bladder cancer; PV; peripheral vein; TUR
Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma
Keywords: TCC; transitional cell carcinoma; BC; bladder cancer; BCG; Bacillus Calmette-Guerin; BPH; Benign prostatic hyperplasia; NMIBC; non-muscle-invasive bladder cancer; MIBC; muscle-invasive bladder cancer; RC; radical cystectomy; CTA; cancer testis antigen; CT
Heme oxygenase-1 expression is associated with tumor aggressiveness and outcomes in patients with bladder cancer: a correlation with smoking intensity
Keywords: CI; confidence interval; COX; cyclooxygenase; HO; heme oxygenase; HPF; high-power field; HR; hazard ratio; IQR; interquartile range; IRS; immunoreactive score; LVD; lymph vessel density; MIBC; muscle invasive bladder cancer; MMP; matrix metalloproteinase;
Pooled Analysis of Clinical Outcomes with Neoadjuvant Cisplatin and Gemcitabine Chemotherapy for Muscle Invasive Bladder Cancer
Keywords: cisplatin; gemcitabine; neoadjuvant therapy; drug therapy, combination; urinary bladder neoplasms; CG; cisplatin and gemcitabine; DFS; disease-free survival; MIBC; muscle invasive bladder cancer; MVAC; methotrexate, vinblastine, doxorubicin, cisplatin; OS
Disease Specific Mortality in Patients with Low Risk Bladder Cancer and the Impact of Cystoscopic Surveillance
Keywords: urinary bladder; urinary bladder neoplasms; risk; cystoscopy; Great Britain; BC; bladder cancer; DSM; disease specific mortality; MIBC; muscle invasive BC; NHS; National Health Service; NMI; nonmuscle invasive; NMIBC; nonmuscle invasive bladder cancer; UC
An unusual synergistic adsorption of MIBC and CTAB mixtures at the air–water interface
Keywords: CTAB; MIBC; Synergism; Air/water interface
Effects of surface forces and film elasticity on foam stability
Keywords: Surface force; Gibbs elasticity; Frother; Foam stability; Flotation; Hydrophobic force; MIBC; PPG-400